The Walt Disney Company (NYSE:DIS) is one of the best inexpensive stocks to invest in right now. Reuters reported on May 26 that The Walt Disney Company (NYSE:DIS), Comcast’s Universal, and Warner Bros Discovery have managed to fend off a bid from China’s MiniMax to dismis
Micron Technology, Inc. (NASDAQ:MU) is one of the best inexpensive stocks to invest in right now. Micron Technology, Inc. (NASDAQ:MU) announced on May 22 the start of 1α DRAM manufacturing at its Manassas, Virginia, fab, which marks a significant step in the company’s effo
Slide Insurance Holdings (NASDAQ:SLDE) Chief Risk Officer Matthew Paul Larson exercised 11,250 stock options and immediately sold the resulting common shares for total proceeds of approximately $209,000, according to a SEC Form 4 filing. Transaction summary Transaction val
Abivax stock fell as much as 40% on Tuesday after the French biotech released late-stage trial data for its ulcerative colitis drug that showed strong efficacy results alongside cancer cases in the higher-dose group, rattling investors and prompting an analyst downgrade. I
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Gilead Sciences, Inc. (NASDAQ:GILD) is one of the most undervalued stocks to invest in TheFly reported on May 27 that GILD presented long-term interim findings from the ongoing Phase
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. GSK plc (NYSE:GSK) is one of the most undervalued stocks in the pharma sector TheFly reported on May 7 that GSK launched a public health awareness initiative under its Ask2BSure campa
Amphastar Pharmaceuticals, Inc. (AMPH) Price Target Cut to $21 At Piper Sandler Amid Pipeline Uncertainty We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is one of the most undervalued pharma
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Grifols, S.A. (NASDAQ:GRFS) is among the most undervalued stocks TheFly reported on May 12 that Deutsche Bank reduced its price target on GRFS from €11 to €10 while reaffirming a Hold
Key Points - Signet Jewelers beat expectations in Q1, with comparable sales up 1.8% and adjusted EPS jumping more than 30% to $1.56. Stronger sales and earnings led the company to raise the midpoint of its full-year guidance. - Higher gold costs pressured margins, but Sign
Citi Trends (NASDAQ:CTRN) reported a sharply stronger first quarter for fiscal 2026, with management pointing to broad-based comparable sales gains, improved margins and expense leverage as evidence that its turnaround strategy is gaining traction. Chief Executive Officer
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.